Allena Pharmaceuticals to Participate in the Stifel 2021 Virtual Healthcare Conference
NEWTON, Mass., Nov. 15, 2021 (GLOBE NEWSWIRE) — Allena Pharmaceuticals, Inc. (NASDAQ: ALNA), a late-stage biopharmaceutical…
Month: November 2021
Eton Pharmaceuticals Reports Third Quarter Financial Results
DEER PARK, Ill., Nov. 15, 2021 (GLOBE NEWSWIRE) — Eton Pharmaceuticals, Inc (Nasdaq: ETON), an…
Terns Pharmaceuticals Reports Third Quarter 2021 Financial Results and Corporate Highlights
-Top-line data readout from TERN-201 (VAP-1) clinical trial in NASH expected in 1Q 2022 -Positive…
Chinook Therapeutics Announces Closing of $183.5 Million Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
SEATTLE, Nov. 15, 2021 (GLOBE NEWSWIRE) — Chinook Therapeutics, Inc. (Nasdaq: KDNY) today announced the…
ImmuCell Announces Unaudited Financial Results for the Third Quarter Ended September 30, 2021
Q3 2021 Net Income of $148,000 versus Q3 2020 Net Loss of ($323,000) PORTLAND, Maine,…
ERYTECH Provides Business and Financial Update for the Third Quarter of 2021
ERYTECH Provides Business and Financial Update for the Third Quarter of 2021 Conference call and…
Aligos Therapeutics to Present Virtually at the Jefferies London Healthcare Conference 2021
SOUTH SAN FRANCISCO, Calif., Nov. 15, 2021 (GLOBE NEWSWIRE) — Aligos Therapeutics, Inc. (Nasdaq: ALGS),…
Icosavax Reports Third Quarter 2021 Financial Results and Provides Corporate Update
– Initiated a Phase 1/1b clinical trial for IVX-121, a virus like particle (VLP) vaccine…
Talis Biomedical Announces Third Quarter 2021 Financial Results and Business Progress
Conference call and webcast today at 4:30pm Eastern/1:30pm Pacific MENLO PARK, Calif., Nov. 15, 2021…
Osmotica Pharmaceuticals plc Reports Third Quarter 2021 Results and Provides Business Update
Third quarter Upneeq® product sales of $2.2 million, representing 47% growth over second quarter sales…
Statera Biopharma Provides Third Quarter 2021 Financial and Corporate Update
Management to Host Conference Call Today, Monday, November 15, 2021, 5:30 p.m. ET FORT COLLINS,…
Talis Biomedical Announces Appointment of Brian Blaser as President, Chief Executive Officer and Director
Veteran executive previously led Abbott’s global diagnostics organization Kim Popovits, interim chief executive officer, to…
CohBar Reports Third Quarter 2021 Financial Results and Provides Business Update
Company to host conference call at 5:00 p.m. ET MENLO PARK, Calif., Nov. 15, 2021…
Fortress Biotech Reports Record Third Quarter 2021 Financial Results and Recent Corporate Highlights
Net revenue for third quarter of 2021 increased 123% year-over-year to $21.1 million, a quarterly…
Agios Appoints Richa Poddar as Chief Commercial Officer
Darrin Miles to Depart Agios to Pursue a Chief Executive Officer Opportunity CAMBRIDGE, Mass., Nov….
Apellis Pharmaceuticals Announces Proposed Public Offering of Common Stock
WALTHAM, Mass., Nov. 15, 2021 (GLOBE NEWSWIRE) — Apellis Pharmaceuticals, Inc., (Nasdaq:APLS), a global biopharmaceutical company…
TFF Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Business Update
Positive Updates Announced for Inhaled Voriconazole and Tacrolimus Programs;Both Programs Advancing into Phase 2 Testing…
Surrozen Reports Third Quarter 2021 Financial Results
Product Candidates SZN-1326 and SZN-043 Advance Toward Initiation of Clinical Studies in 2022 Expanding and…
Valneva to Present its Chikungunya Vaccine Candidate at the ASTMH 2021 Annual Meeting
Saint–Herblain (France), November 15, 2021 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty…
NYMOX Presenting at Torrey Hills Capital Emerging Growth Conference
NYMOX Provides Current Update HASBROUCK HEIGHTS, N.J., Nov. 15, 2021 (GLOBE NEWSWIRE) — Nymox Pharmaceutical…